Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    Ramin Kordi, Nicola Maffulli, Randall R. Wroble, W. Angus Wallace, editors.
    Digital Access Springer 2009
  • Article
    Chessells JM, Cornbleet M.
    Med Pediatr Oncol. 1979;6(4):359-65.
    Thirty-four children with acute lymphoblastic leukaemia (ALL) in relapse or resistant to initial induction received combination chemotherapy with prednisolone, vincristine, l-asparaginase, and daunorubicin. L-asparaginase was given subcutaneously on alternate days for four weeks and was well tolerated. A complete remission was achieved in 96% of children in relapse and in five out of six children resistant to induction. Remission was achieved without hospitalisation in over 60% of patients. The median duration of subsequent remission was only 13 weeks, but six out of eight children receiving a second course of the drug combination achieved a further remission. We conclude that prolonged l-asparaginase therapy in combination with an anthracycline might well be used in initial or consolidation therapy for childhood ALL.
    Digital Access Access Options